| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/14/2002 | CA2421018A1 Dihydroxy open-acid salt of simvastatin |
| 03/14/2002 | CA2420703A1 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 03/14/2002 | CA2419456A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 03/14/2002 | CA2417594A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 03/14/2002 | CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | CA2412279A1 "pseudo"-native chemical ligation |
| 03/14/2002 | CA2412278A1 Polymer-modified synthetic proteins |
| 03/14/2002 | CA2412277A1 Synthetic erythropoiesis stimulating proteins |
| 03/13/2002 | EP1186672A2 Polymorphisms in the human organic anion transporter C (OATP-C) gene |
| 03/13/2002 | EP1186603A2 Processes for preparing endothelin antagonists |
| 03/13/2002 | EP1186601A1 Novel isoquinoline derivatives or salts thereof |
| 03/13/2002 | EP1186304A2 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| 03/13/2002 | EP1186303A2 Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist |
| 03/13/2002 | EP1186299A1 The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system |
| 03/13/2002 | EP1186297A2 Agent for preventing, improving or treating hypertension |
| 03/13/2002 | EP1186294A2 Ferulic acid and caffeic or chlorogenic acids containing compositions for alleviating hypertension or preventing a rise in blood pressure |
| 03/13/2002 | EP1186293A2 Intermittent administration of a growth hormone secretagogue |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185694A1 49 human secreted proteins |
| 03/13/2002 | EP1185666A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 03/13/2002 | EP1185645A1 Adipocyte complement related protein homolog zacrp7 |
| 03/13/2002 | EP1185643A1 Adipocyte complement related protein homolog zacrp5 |
| 03/13/2002 | EP1185635A2 Non-human transgenic animals deficient in gas6 function and their use |
| 03/13/2002 | EP1185632A1 Caspase-8 crystals, models and methods |
| 03/13/2002 | EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 03/13/2002 | EP1185553A1 Heart homing peptides and methods of using same |
| 03/13/2002 | EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | EP1185532A1 Peroxynitrite decomposition catalysts and methods of use thereof |
| 03/13/2002 | EP1185527A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 03/13/2002 | EP1185525A1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 03/13/2002 | EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 03/13/2002 | EP1185516A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 03/13/2002 | EP1185512A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185511A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185316A1 Devices and compounds for treating arterial restenosis |
| 03/13/2002 | EP1185302A2 Specifically targeted catalytic antagonists and uses thereof |
| 03/13/2002 | EP1185295A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 03/13/2002 | EP1185292A2 Use of interleukin-11 to treat hemorrhagic shock |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185277A1 Methods for modulating fxr receptor activity |
| 03/13/2002 | EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 03/13/2002 | EP1185274A1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 03/13/2002 | EP1185271A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185270A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185265A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185261A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP1185246A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water |
| 03/13/2002 | EP1185175A1 Method of increasing the content of flavonoids and phenolic substances in plants |
| 03/13/2002 | EP0977749B1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 03/13/2002 | EP0876343B1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
| 03/13/2002 | EP0600010B1 USE OF RELAXIN for the manufacture of a medicament for the treatment of CARDIOVASCULAR diseases. |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340098A Astrocytes, their preparation and use thereof |
| 03/13/2002 | CN1340059A Peptides |
| 03/13/2002 | CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/13/2002 | CN1340052A Process for the production of tert-butyl (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin 5-yl] (4R,6S)-2,2-dimethyl [1,3] dioxan-4-yl) acetate |
| 03/13/2002 | CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents |
| 03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
| 03/13/2002 | CN1340046A β－丙氨酸衍生物 β- alanine derivatives |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/13/2002 | CN1339973A Gene therapy for diabetic ischemic disease |
| 03/13/2002 | CN1339966A Medicament for treating hypertension |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances |
| 03/13/2002 | CN1339604A Gene carrier with glandular relative virus terminal sequence and its use |
| 03/13/2002 | CN1339309A Preparing process for haw and ginkgo leaf capsule |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/12/2002 | US6355809 Method for preparing (2s)-1-(2r3s)-5-chloro-3-(2-chlorophenyl) -1-(3,4-dimethoxy benzene-sulphonyl) 3-hydroxy-2,3-dihydro-1h-indole-2-carbonyl pyrrolidine-2-carboxamide |
| 03/12/2002 | US6355808 Benzimidazole compounds, their production and use |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355689 Antiinflammatory agents |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355680 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/12/2002 | US6355658 Coumarin derivatives, methods of preparation and application as medicines |
| 03/12/2002 | US6355653 Amino-triazolopyridine derivatives |
| 03/12/2002 | US6355643 Enzyme inhibitors, ras genes and proteins |
| 03/12/2002 | US6355640 Pyrazolopyridine adenosine antagonists |
| 03/12/2002 | US6355632 Naphthyl compounds, intermediates, compositions, and methods |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 03/12/2002 | US6355269 Oral compositions of levosimendan |
| 03/12/2002 | US6355265 Over-coated chewing gum formulations |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355243 Method of thrombolysis by local delivery of active plasmin |
| 03/12/2002 | CA2313783C Pharmaceutical compositions of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a salt thereof |
| 03/12/2002 | CA2099262C (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl]hydrazono]propanedinitrile |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018593A2 Modulation of fas and fasl expression |